
NYSE:GL
This summary was created by AI, based on 7 opinions in the last 12 months.
Globe Life Inc. (GL-N) has consistently been highlighted as a top pick by Stockchase Research Editor Michael O'Reilly, reflecting strong performance indicators. The company has seen a significant increase in book value per share over the past two years, along with impressive quarterly cash reserves. With a focus on aggressively buying back shares and a stable return on equity of around 20-22%, GL is considered a solid long-term investment. Analysts have set price targets ranging from $168.70 to $215.00, indicating potential upside from current levels. The stock trades at attractive earnings multiples, making it a compelling option during market volatility.
Globe Life Inc. is a American stock, trading under the symbol GL (previously GL-N on Stockchase) on the New York Stock Exchange (GL). It is usually referred to as NYSE:GL or GL
In the last year, 8 stock analysts issued a Buy, Sell, or Hold rating on GL (previously GL-N on Stockchase). 8 analysts recommended to BUY and 0 analysts recommended to SELL the stock. The latest stock analyst rating is TOP PICK. Read the latest stock experts' ratings for Globe Life Inc..
Globe Life Inc. was recommended as a Top Pick by The Panic-Proof Portfolio (Stockchase Research) on 2026-07-09. Read the latest stock experts ratings for Globe Life Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Globe Life Inc..
Globe Life Inc. is covered by Stockchase experts and is worth watching.
On 2026-07-24, Globe Life Inc. (GL) stock closed at a price of $172.50.
We again reiterate GL as a TOP PICK. The insurance provider recently reported book value per share has increased 20% annually over the past two years. It trades at 12x earnings, 2.3x book and supports a 20% ROE. Quarterly cash reserves are growing while shares are aggressively bought back, albeit using slightly more debt. We continue to recommend a stop at $165, looking to achieve $208 -- upside potential of 16%. Yield 0.6%
(Analysts’ price target is $215.00)